id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0790-0004,FDA,FDA-2011-D-0790,"Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Staff; Availability: Decisions for Investigational Device Exemption Clinical Investigations",Notice,Notice of Extension,2011-12-27T05:00:00Z,2011,12,2011-12-27T05:00:00Z,2012-03-10T04:59:59Z,2011-12-27T17:03:18Z,2011-33141,0,0,0900006480f89877
FDA-2011-D-0790-0001,FDA,FDA-2011-D-0790,"Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Staff; Availability: Decisions for Investigational Device Exemption Clinical Investigations",Notice,Notice of Availability,2011-11-10T05:00:00Z,2011,11,2011-11-10T05:00:00Z,2012-02-09T04:59:59Z,2011-11-10T14:10:31Z,2011-29118,0,0,0900006480f69c13
FDA-2011-D-0790-0002,FDA,FDA-2011-D-0790,"Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Food and Drug Administration Staff, FDA Decisions for Investigational Device Exemption Clinical Investigations",Other,Guidance,2011-11-10T05:00:00Z,2011,11,2011-11-10T05:00:00Z,2012-02-09T04:59:59Z,2011-11-10T14:18:11Z,,0,0,0900006480f69b65